- Research
- Open access
- Published:
First real-time imaging of bronchoscopic lung volume reduction by electrical impedance tomography
Respiratory Research volume 25, Article number: 264 (2024)
Abstract
Background
Bronchoscopic lung volume reduction (BLVR) with one-way endobronchial valves (EBV) has better outcomes when the target lobe has poor collateral ventilation, resulting in complete lobe atelectasis. High-inspired oxygen fraction (FIO2) promotes atelectasis through faster gas absorption after airway occlusion, but its application during BLVR with EBV has been poorly understood. We aimed to investigate the real-time effects of FIO2 on regional lung volumes and regional ventilation/perfusion by electrical impedance tomography (EIT) during BLVR with EBV.
Methods
Six piglets were submitted to left lower lobe occlusion by a balloon-catheter and EBV valves with FIO2 0.5 and 1.0. Regional end-expiratory lung impedances (EELI) and regional ventilation/perfusion were monitored. Local pocket pressure measurements were obtained (balloon occlusion method). One animal underwent simultaneous acquisitions of computed tomography (CT) and EIT. Regions-of-interest (ROIs) were right and left hemithoraces.
Results
Following balloon occlusion, a steep decrease in left ROI-EELI with FIO2 1.0 occurred, 3-fold greater than with 0.5 (p < 0.001). Higher FIO2 also enhanced the final volume reduction (ROI-EELI) achieved by each valve (p < 0.01). CT analysis confirmed the denser atelectasis and greater volume reduction achieved by higher FIO2 (1.0) during balloon occlusion or during valve placement. CT and pocket pressure data agreed well with EIT findings, indicating greater strain redistribution with higher FIO2.
Conclusions
EIT demonstrated in real-time a faster and more complete volume reduction in the occluded lung regions under high FIO2 (1.0), as compared to 0.5. Immediate changes in the ventilation and perfusion of ipsilateral non-target lung regions were also detected, providing better estimates of the full impact of each valve in place.
Trial registration
Not applicable.
Background
Bronchoscopic lung volume reduction (BLVR) with one-way endobronchial valves (EBV) is a minimally invasive endoscopic procedure that improves clinical outcomes in selected emphysema patients with severe hyperinflation [1, 2]. Best outcomes are achieved when atelectasis of the target lobe occurs after BLVR with EBV [3] and in the absence of collateral ventilation (CV) between the target and adjacent lobe(s), which favors lobar atelectasis [4].
In human lungs, the quantity and resistance of CV channels varies widely, requiring individual assessment, particularly when radiographic evaluation of the interlobar fissures between the target and adjacent lobes shows an integrity below 95% [5,6,7]. In such instances, the bronchoscopic assessment of CV is necessary by means of a balloon catheter connected to a dedicated device that measures real-time CV [4]. Once the negative collateral ventilation (CV-) is ascertained, the EBV valves are placed in the segmental bronchi of the target lobe.
Despite being the best candidates for BLVR with EBV, CV- patients have a 15 to 27% probability of developing a pneumothorax in the non-treated emphysematous lobe(s) after valve placement [8,9,10]. Approximately 86% of the pneumothorax events occur within 3 days following BLVR [10,11,12]. Parenchymal interdependence is thought to be the main physiological mechanism underlying such pneumothorax events. The mechanism involves the targeted lobar deflation, which may cause overinflation of ipsilateral lobe(s), resulting in a tear of emphysematous ipsilateral lobe(s), resulting in pneumothorax. There is an increased local strain after stress redistribution, particularly within adjacent non-target lobes [13].
Oxygen is rapidly absorbed through the alveolar-capillary barrier playing an important role in atelectasis formation in patients under general anesthesia, especially when associated with airway occlusion [14,15,16]. These conditions have similarities with the intended effect of EBV. However, the real-time kinetics of all the regional acute effects of the inspired oxygen fraction (FIO2) on BLVR with EBV are poorly understood. This would require a bedside monitoring tool capable of providing real-time and continuous information on regional lung volumes, or more precisely in the strain map of the lung after BLVR with EBV placement.
Electrical impedance tomography (EIT) is a non-invasive, bedside lung imaging tool that provides real-time and continuous information on regional changes in end-expiratory lung volume [17] and strain, as well as regional changes in lung ventilation and perfusion [18,19,20]. Changes in lung function during bronchoscopic procedures have also been monitored with EIT [21, 22]. Furthermore, EIT can also accurately detect the early onset of pneumothorax [23, 24].
This experimental study focused on using EIT imaging to investigate the real-time effects of different FIO2 on regional lung volumes and regional ventilation/perfusion during BLVR with EBV in a CV- animal model. We hypothesized that a higher FIO2 during airway occlusion induces greater effects in lung volume reduction, and such changes could be early and precisely detected by EIT, as well as the distinct responses on the non-targeted ipsilateral lung regions. We also present two illustrative clinical cases of BLVR with EBV. The information provided by EIT monitoring was relevant and timely related to key mechanisms that materialized in the post-BLVR evolution and to the clinical outcomes in these patients.
Methods
Additional details on the study design and methods are provided as Supplementary Information (See Supplementary Information 1, Additional File 1). This study was approved by the ethics committee for experimental studies of the Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil (CEUA 200 − 12), and by the ethics committee for clinical studies (CAAe 43250215.0.1001.5327 and CAPPesq 0689 − 11).
Animal experiments
Six healthy female Landrace piglets were anesthetized. In a crossover study design, they were submitted to two occlusion methods (Balloon and Valves) and two FIO2 (0.5 and 1.0). The occlusion method order was fixed with Balloon first (See Supplementary Figure S1, Additional File 2). The FIO2 order was randomized.
Balloon occlusion method
Bronchial occlusion of the left lower lobe (LLL) was achieved by the placement of an indwelling inflatable Chartis™ balloon-catheter (Chartis™, Pulmonx Inc. USA) under bronchoscopic view. The following time points were analyzed: Pre [under standard mechanical ventilation (MV) settings; See Supplementary Figure S1, Additional File 2]; Broncho (1 min after positioning the bronchoscope in the LLL bronchus); T0 (when complete LLL bronchial occlusion with the balloon was achieved); and each minute from T1 to T15 (1 to 15 min of occlusion).
Valves occlusion method
The bronchoscopic placement of one-way endobronchial valves EBV Zephyr™ 4.0–5.5 mm (Pulmonx Inc. USA) was carried out under bronchoscopic view and endobronchial valves were deployed in the segmental bronchi of the LLL. The following time points were analyzed: Pre (under standard MV settings); Broncho (1 min after positioning the bronchoscope in the LLL bronchus); T0 (when complete LLL bronchial occlusion with the valves was achieved); and each minute from T1 to T15 (1 to 15 min of occlusion); T30 and T45 (30 and 45 min of occlusion).
EIT
Regional Lung Volumes and Regional Ventilation functional lung images were generated [18, 25, 26]. Measurements were regional tidal impedance variation (TIV) and regional end-expiratory lung impedance (EELI) [17, 19]. Data were relative to Pre values. Perfusion Distributions were acquired as previously described [20]. The images were sub-segmented into two regions-of-interest (ROIs): Right and Left hemithorax.
Computed tomography scans
Helical computed tomography (CT) scans and EIT imaging were simultaneously acquired in one piglet. The time points Pre, each minute from T0 to T5, and T15 were analyzed as regards to the CT-derived gas content. Dynamic contrast-enhanced CT perfusion distributions, as described in detail elsewhere [27, 28], were also acquired at the time points Pre and T15, having corresponding EIT perfusion distributions.
Local pocket pressure
During the Balloon Occlusion Method, a pressure transducer was connected to a hollow catheter to provide continuous recordings of the pressure changes in the air pocket distal to the occluded bronchi. This methodology has been described in detail previously [29, 30].
Patients observations
The observations in the first patient focused on the CV evaluation to define the target lobe where CV was absent. The observations of the second patient focused on the periods before, during, and after the EBV Zephyr™ valve placement. EIT images were sub-segmented into the same ROIs as the piglets.
Statistical analysis
The assumptions of a normal distribution in each group and the homogeneity of the variances between groups were evaluated with the Shapiro-Wilk and Levene tests. A two-way analysis of variance (ANOVA) was used for a two-factor analysis (group and time), and Bonferroni adjustment for multiple tests was applied for post-hoc comparisons. Statistical significance was considered for p values less than 0.05. Values presented are mean and SEM unless otherwise stated.
Results
Additional details on the results are provided as Supplementary Information (See Supplementary Information S1, Additional File 1).
Experimental data
The six piglets completed the study protocol and were included in the analyses. All EIT data on regional TIV and EELI were available for analysis. The individualized optimum positive end-expiratory pressure (PEEP) was 16 ± 2 cmH2O. The MV parameters, physiological measurements, and respiratory system mechanics for both occlusion methods are shown (See Supplementary Tables S1 and S2, Additional Files 3 and 4).
Balloon occlusion method
The bronchoscope insertion did not affect regional EELI compared to the Pre values. Following balloon occlusion, there was a steep decrease of the EELI of the left ROI with FIO2 1.0 (Fig. 1), which was 3-fold greater than in FIO2 0.5 (p < 0.001). The EELI of the right ROI did not change over time in both FIO2. The TIV of both hemithoraces decreased to approximately half with the introduction of the bronchoscope. With the balloon occlusion, the left ROI presented an additional decrease and a contralateral increase during both FIO2 regimens (Broncho vs. T0: FIO2 1.0, p < 0.01; FIO2 0.5, p = 0.01). Then, the regional TIV of both hemithoraces remained unchanged for 15 min (Fig. 1).
Valves occlusion method
Five animals received three valves; one required four valves to occlude the LLL segments. All valve deployments were in place within 3 min. The insertion of the bronchoscope in the LLL did not change regional EELI. Under the FIO2 1.0, at T0 and onwards, there was a progressive reduction of the left ROI EELI (Pre vs. T0: p < 0.01). The same did not occur with FIO2 0.5. Regardless of the FIO2, the right ROI EELI showed no significant differences (Fig. 1). The TIV of both hemithoraces showed a 50% decrease after the insertion of the bronchoscope. During occlusion and onwards, this reduction was maintained in the TIV measurements of the left ROI. On the other hand, following the bronchoscope withdrawal, the right ROI’s TIV returned to Pre values and remained unchanged for 45 min (Fig. 1). The regional TIV data was not different between the two FIO2 regimens.
CT and EIT images
The CT and EIT data acquired in one animal illustrates and corroborates the data observed in the other animals. The EELI of the right ROI remained unchanged regardless of the FIO2. Conversely, the EELI of the left ROI, which contains the occluded LLL, decreased and showed a significantly greater decrease with FIO2 1.0 when compared to FIO2 0.5 (Fig. 2). The CT-derived gas content data paralleled the EELI findings consistently. The Pre vs. T15 CT images showed the faster evolution of atelectasis under FIO2 1.0 (Fig. 3). In addition, the T15 CT images with FIO2 1.0 were also clearly different between the two occlusion methods (Fig. 3). FIO2 1.0 resulted in complete atelectasis with the balloon and partial atelectasis with the valves.
The dynamic contrast-enhanced CT perfusion and EIT perfusion distributions, acquired at steps Pre and T15 in this animal, presented an apparent decrease of perfusion within the left ROI at T15 (Fig. 4). There were no clear differences between the two FIO2.
EIT perfusion distributions, acquired at steps Pre and T45 in five animals and Pre and T15 in one animal (the one studied by CT): decreased significantly between Pre and T45/T15, with no difference between the FIO2.
Local pocket pressure
The corresponding regional EELI and the pressure changes of the air pocket distal to the balloon occlusion are depicted in Fig. 5. Data were acquired simultaneously in both FIO2 regimens. The local pocket pressure and its corresponding regional EELI paralleled each other. Noteworthy, a negative local pocket pressure was obtained at 4 min and thereon under FIO2 1.0 in one animal with the longest stable measurement.
Patient data
Two patients were submitted to BLVR with EBV. The EIT imaging was obtained during the BLVR procedure. Additional details on the patient data are provided as Supplementary Information (See Supplementary Information S1, Additional File 1).
First Patient (Figure. 6).
A 62-year-old female with emphysema and eligible to undergo BLVR treatment was submitted to a preprocedural bronchoscopy for CV assessment to define the target lobe. Under conscious sedation, topical anesthesia of the larynx, trachea, and bronchi and spontaneous breathing, a therapeutic flexible videobronchoscope advanced into the airway through a laryngeal mask. A Chartis™ catheter with a balloon tip was inserted into the bronchoscope working channel, advanced into the target left upper lobe bronchus, and inflated to complete bronchial occlusion. A continuous tracing of the pressure and expired flow of the occluded lobar bronchus was recorded by a Chartis™ console. The absence of CV created a gradual decrease in expiratory flow with an increase in the negative pressure and airway resistance. Such findings became apparent within the first minute of the balloon occlusion of the target lobe. The EIT acquisition started during the assessment of the right upper lobe, followed by the assessment of the left upper lobe. The patient received four EBV-Zephyr™ valves in the left upper lobe.
Second Patient (Fig. 7; See Supplementary Video S1, Additional File 5).
Anesthetic and endoscopy procedures were like those described for the first patient. A Chartis™ catheter was advanced into the right lower lobe bronchus of a 71-year-old male with emphysema, and CV- was recorded by the Chartis™ console. Three EBV Zephyr™ valves were placed in the right lower lobe segmental bronchi. Upon completion of the BLVR procedure and withdrawal of the laryngeal mask during recovery from the sedation with the patient in the operating room, he had a sudden coughing spell followed immediately by dyspnea, right-sided chest pain, and a steep decrease in peripheral capillary oxygen saturation (SpO2), from 98 to 80%. Immediately before the sudden coughing spell, the EIT tracings showed a quick rise in the regional EELI of the right hemithorax, combined with a corresponding significant attenuation of the regional ventilation within the same right ROI, which are characteristic changes in the EIT signals suggestive of a pneumothorax [23]. As the patient’s respiratory condition rapidly deteriorated, becoming critical, in addition to the accompanying real-time EIT tracings and images for pneumothorax altogether, allowed us to proceed with an emergency right-sided chest tube drainage. It was followed by an improvement of the dyspnea and pain, yielding to stabilization of the ventilatory condition and SpO2 within a few minutes.
Discussion
To our knowledge, this is the first study using EIT imaging to examine the real-time effects of high vs. low FIO2 during BLVR with EBV. We purposely selected a pig model that is CV- [31] because it simulates the ideal conditions for BLVR with one-way valves. In addition, the pig has a severe hypoxic pulmonary vasoconstriction (HPV) reflex that helps in its ventilation-perfusion (V̇/Q̇) balance [32]. Under such conditions, high FIO2 significantly amplifies the acute dynamics of lung volume reduction.
The foundations of BLVR explored the sustained lobar atelectasis to promote lung volume reduction without surgery [33]. In a landmark elegant study in a sheep model of emphysema produced by inhalation of papain, the authors demonstrated alveolar instability induced by FIO2 1.0 for 15 min before occlusion and wash out of the surfactant within the target segment. There are similarities between that study and our present study regarding the underlying mechanisms and interventions. Ingenito and colleagues [33] found that the obliteration of dysfunctional regions of the hyperinflated lung could be achieved nonoperatively by a bronchoscopic production of sustained collapse by the following procedures: (a) filling target regions with oxygen, benefiting from its high absorption coefficient, which promotes reabsorption atelectasis; (b) using an airway occlusion method; in our case with either our inflatable balloon or EBV whereas in their case by the injection of a biocompatible fibrin-based glue acting as a sealant. In the last statement of their seminal paper, the authors encouraged a more highly refined approach to BLVR. Our investigation moves one step further in this direction.
Alveolar collapse has been associated with hypoventilation and airway closure during general anesthesia. The prevention of atelectasis has been attempted with the use of a titrated PEEP [34] or by lower FIO2, particularly before the induction of anesthesia [14,15,16, 35]. Nitrogen is a break for the gas absorption within the air pocket generated by airway occlusion. It increases the time to achieve atelectasis from as low as 4 to 6 min with FIO2 1.0, to 6 to 8 h with FIO2 0.21 [35, 36]. The driving force of gas absorption rate is a function of the pressure gradient between alveolar and mixed-venous gas concentrations, the absorption coefficient of each gas, and local blood flow [35,36,37]. Our data showed a larger EELI decrease with FIO2 1.0. Notwithstanding, during balloon occlusion, approximately 90% of the lobar volume reduction occurred within the first 5 min in both FIO2 regimens (Fig. 1). It reflects the initial higher absorption rate of oxygen that decelerates proportionally as the concentration gradient decreases.
The CT images and data supported the EIT findings. It shows that the steepest fall in the regional CT-derived gas content achieved with FIO2 1.0 is likely derived from the exhaustion of all gas content within the occluded segment. Conversely, under FIO2 0.5 the reduction of the gas content does not necessarily result in atelectasis in the short term because nitrogen still supports the alveoli (Fig. 3). The regional CT-derived gas content and regional EELI findings data presented a notable matching (Fig. 2). Likewise, the local pocket pressure and EELI data showed an apparent matched behavior over time. The FIO2 1.0 yielded a steeper decay in volumes and pressures when compared to FIO2 0.5, reaching sub atmospheric pressures. These negative pressures likely indicate negative pleural/interstitial pressures created by interdependence forces generated by extreme volume reduction of the target lobe as compared to the surroundings (Fig. 5). This situation mimics the final result of a successful valve much more than the results at FIO2 0.5.
Concerning such dynamics of volume reduction resulting from the gas absorption following lobar occlusion, the findings reinforce that FIO2 1.0 yields a faster and more significant volume reduction than FIO2 0.5, which relies on nitrogen to slow down the atelectasis induction once oxygen is absorbed. While EELI detected the dynamics of the occluded area, TIV expressed the behavior of the non-occluded lung regions. Our results showed a dissociation between the two. The EELI was both FIO2 and time-dependent, whereas the TIV changes were immediate and neither dependent on FIO2 nor its effects on EELI within the region. Of note, regional ventilation of the non-occluded areas increased immediately after balloon or valve occlusion.
The decrease in perfusion distribution found with EIT and CT perfusion measurements after 15 min of occlusion of the LLL, regardless of FIO2, corroborates the hypothesis of complete oxygen consumption followed by regional hypoxia within occluded areas. A strong HPV reflex was described previously in piglets to be triggered by local partial pressure of oxygen between 25 and 50 mmHg [38]. Perfusion distribution in emphysema varies widely, considering the increase of CV as an adaptive resource for V̇/Q̇ adjustments [39], in addition to the inverse relation between CV and HPV reflex [40]. In patients submitted to BLVR with EBV, V̇/Q̇ scintigraphy evaluations pre- and post-intervention showed a proportional reduction of perfusion in the treated lobe and a contralateral compensatory increase [41]. Thomsen and colleagues [42] showed a positive correlation between high non-target ipsilateral lobe perfusion and 6 min-walk distance test.
Pneumothorax after BLVR is a feared complication following lobar atelectasis. This patient population has a high relative risk and an incidence between 18 and 34% in clinical trials [43]. Approximately 86% occur within the first 72 h post-BLVR [44], and it is a potentially life-threatening situation [45]. A randomized clinical trial with EBV Zephyr valves (Liberate Trial) [10] reported a 26.6% incidence of pneumothorax. Post-BLVR atelectasis is a surrogate for better functional outcomes, and pneumothorax does not influence long-term survival [46]. The predictors of pneumothorax post-BLVR are based on static CT imaging data, including the presence of pleural-pulmonary adhesions, large volume of the ipsilateral untreated lobe over the volume of the hemithorax (whose effects on it are real-time detectable by EELI monitoring from EIT), emphysema type, fissure integrity, poor lung function, and exercise testing. Such factors yield a high probability of post-BLVR pneumothorax (84%) [12].
Egenod and Born [47, 48] proposed and performed a sequential placement of EBV-Zephyr valves in the target lobe by splitting the procedure into two stages one month apart. All but one endobronchial valve are placed in the first stage, and the last and more proximal valve is placed four weeks later. This strategy decreased the incidence of post-BLVR pneumothorax from 25 to 9%. Nevertheless, this BLVR with staged valve placement procedure has not yet reached a consensus due to the increased risk of bronchoscopy-related complications [49], and awaits a proper randomized controlled trial.
Lentz and colleagues hypothesized that a lower FIO2 during BLVR with EBV could slow absorption atelectasis by preventing nitrogen wash-out of the treated lung and reducing the incidence of pneumothorax [50]. The authors demonstrated that a low FIO2, compared with high FIO2 during BLVR with EBV was associated with a marked reduction in the incidence of post-procedure pneumothorax [50]. Furthermore, approximately 22% of the pneumothoraces in the high FIO2 group occurred during the first hour after the procedure thus supporting that atelectasis drives pneumothorax in high FIO2 patients. Our study may challenge this perspective for two reasons: first, the low FIO2 may decrease the chances of pneumothorax but, at the same time, they might decrease the efficiency and impact of each valve, as suggested in Fig. 1; and secondly, instead of promoting a slower reabsorption, we might propose a faster one, mimicking the full, long-term effect of a single valve, but monitoring the impact in real-time. This could result in fewer valves in place, but each of them with a maximized impact.
Based on the EIT’s ability to detect regional lung volume changes and ventilation shifts in real-time, we hypothesized that its use during the BLVR procedure could show the ventilation shifts that occur immediately after the procedure and potentially anticipate post-procedural pneumothorax, as shown in the two patient observations described.
Study limitations
The CT data was obtained only in one animal as to illustrate and demonstrate lung volume reduction. The EIT-based regional analysis are both bidimensional (data are provided by electrodes placed in a single plane representing the axial view), and tridimensional (the finite elements mesh model assumes a 3-D propagation of current and voltage field). This results in an EIT cross-sectional slice with approximately 15 cm of thickness, although this may vary with the size and shape of the animal [51]. This property could potentially limit the detection of localized changes in lung volume occurring within the apical zones of the lung.
Despite the amount of data and the study’s consistent findings, data came from a few animals with healthy lungs. We were expecting more pronounced effects in the contralateral EELI (i.e. a contralateral increase), as observed in two animals, but not in all. The lack of consistent effects in the contralateral EELI, as opposed to ipsilateral non-target lung regions, can derive from normal lung compliance and less parenchymal heterogeneity, as opposed to an emphysematous lung. Of note, although the EIT data did not show a contralateral volume increase, the CT images show a considerable expansion of the accessory lobe, displaced towards the left hemithorax.
Lastly, the right and left hemithoraces (ROIs) segmentation used a division based on the mediastinum midline. The invasion of the left ROI following the volumetric increase of the accessory lobe may have decreased the left ROI sensitivity. Such limitation derives from the EIT spatial reconstruction algorithms and the challenging anatomical segmentation of individual lobes.
Clinical implications
The development of lung volume reduction procedures identified several physiological mechanisms [33, 52]. In patients with severe emphysema eligible to BLVR with EBV valves, the best results are related to the absence of significant CV between the target and ipsilateral lobe(s), resulting in lobar atelectasis and, thereby, an effective lung volume reduction [4]. On the other hand, as illustrated by the current study, the onset of complete lobar atelectasis of the treated lobe triggers a fast and immediate intrathoracic negative pressure and non-target lobe hyperdistention that increases the chance of pneumothorax. We tested the impact of different FIO2 during this procedure as a proof-of-concept study in a well-controlled experimental setting. It showed that faster volume reduction can be achieved with higher FIO2, enhancing the final impact of EBV valves. Although the chances of pneumothorax could be potentially increased, the real-time monitoring with EIT would allow us to stop the procedure once a pre-specified volume reduction and ventilation redistribution was achieved. This procedure would also favor the maximal impact of each valve in place.
We acknowledge that the impact of other variables such as PEEP and MV mode, or the decision to maintain or not the patient’s respiratory drive during mechanical ventilation [4] must be considered. The study results are the basis for future clinical studies addressing EIT imaging to monitor and manage these complex, challenging, and variable patients in real-time.
EIT emerges as a non-invasive technology able to provide meaningful information that can contribute to the safety of BLVR as a peri-procedural monitoring tool, particularly for intraoperative decision-making and early detection of complications such as pneumothorax.
Conclusions
EIT monitoring demonstrated, in real-time, a significant and faster volume reduction in the occluded lung region under FIO2 1.0 if compared to FIO2 0.5. Moreover, EIT imaging also could track the behavior of ipsilateral non-target lung regions, such as an increase of regional ventilation of the ipsilateral non-target region, as an indicator of an increased risk and early detection of a pneumothorax. By providing continuous information on regional lung volume changes, EIT is a promising tool for intraprocedural decision-making during bronchoscopic lung volume reduction, which can potentially impact the decision-making between the single or sequential treatment of the target lobe(s) and the subsequent clinical outcomes.
Data availability
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- ANOVA:
-
Analysis of variance
- BLVR:
-
Bronchoscopic lung volume reduction
- CT:
-
Computed tomography
- CV:
-
Collateral ventilation
- CV-:
-
Negative collateral ventilation
- EBV:
-
One-way endobronchial valves
- EELI:
-
End-expiratory lung impedance
- EIT:
-
Electrical impedance tomography
- FIO2 :
-
Fraction of inspired oxygen
- HPV:
-
Hypoxic pulmonary vasoconstriction
- LLL:
-
Left lower lobe
- MV:
-
Mechanical ventilation
- PEEP:
-
Positive end-expiratory pressure
- ROI(s):
-
Region(s)-of-interest
- SpO2 :
-
Peripheral capillary oxygen saturation
- TIV:
-
Tidal impedance variation
- V̇/Q̇:
-
Ventilation-perfusion
References
Shah PL, Slebos DJ. Bronchoscopic interventions for severe emphysema: where are we now? Respirology. 2020;25:972–80.
Klooster K, Slebos DJ. Endobronchial valves for the Treatment of Advanced Emphysema. Chest. 2021;159:1833–42.
Hopkinson NS, Kemp SV, Toma TP, Hansell DM, Geddes DM, Shah PL, Polkey MI. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J. 2011;37:1346–51.
Slebos DJ, Shah PL, Herth FJ, Valipour A. Endobronchial valves for endoscopic lung volume reduction: best practice recommendations from Expert Panel on endoscopic lung volume reduction. Respiration. 2017;93:138–50.
Morrell NW, Wignall BK, Biggs T, Seed WA. Collateral ventilation and gas exchange in emphysema. Am J Respir Crit Care Med. 1994;150:635–41.
Pu J, Wang Z, Gu S, Fuhrman C, Leader JK, Meng X, Tedrow J, Sciurba FC. Pulmonary fissure integrity and collateral ventilation in COPD patients. PLoS ONE. 2014;9:e96631.
Sciurba FC, Ernst A, Herth FJ, Strange C, Criner GJ, Marquette CH, Kovitz KL, Chiacchierini RP, Goldin J, McLennan G, Group VSR. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010;363:1233–44.
Valipour A, Slebos DJ, de Oliveira HG, Eberhardt R, Freitag L, Criner GJ, Herth FJ. Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema–potential mechanisms, treatment algorithm, and case examples. Respiration. 2014;87:513–21.
Fiorelli A, D’Andrilli A, Bezzi M, Ibrahim M, Anile M, Diso D, Cusumano G, Terminella A, Luzzi V, Innocenti M, et al. Complications related to endoscopic lung volume reduction for emphysema with endobronchial valves: results of a multicenter study. J Thorac Dis. 2018;10:S3315–25.
Criner GJ, Sue R, Wright S, Dransfield M, Rivas-Perez H, Wiese T, Sciurba FC, Shah PL, Wahidi MM, de Oliveira HG, et al. A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE). Am J Respir Crit Care Med. 2018;198:1151–64.
Gompelmann D, Herth FJ, Slebos DJ, Valipour A, Ernst A, Criner GJ, Eberhardt R. Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration. 2014;87:485–91.
Gompelmann D, Lim HJ, Eberhardt R, Gerovasili V, Herth FJ, Heussel CP, Eichinger M. Predictors of pneumothorax following endoscopic valve therapy in patients with severe emphysema. Int J Chron Obstruct Pulmon Dis. 2016;11:1767–73.
Brown MS, Kim HJ, Abtin FG, Strange C, Galperin-Aizenberg M, Pais R, Da Costa IG, Ordookhani A, Chong D, Ni C, et al. Emphysema lung lobe volume reduction: effects on the ipsilateral and contralateral lobes. Eur Radiol. 2012;22:1547–55.
Rothen HU, Sporre B, Engberg G, Wegenius G, Reber A, Hedenstierna G. Prevention of atelectasis during general anaesthesia. Lancet. 1995;345:1387–91.
Edmark L, Kostova-Aherdan K, Enlund M, Hedenstierna G. Optimal oxygen concentration during induction of general anesthesia. Anesthesiology. 2003;98:28–33.
Hedenstierna G, Rothen HU. Respiratory function during anesthesia: effects on gas exchange. Compr Physiol. 2012;2:69–96.
Hinz J, Hahn G, Neumann P, Sydow M, Mohrenweiser P, Hellige G, Burchardi H. End-expiratory lung impedance change enables bedside monitoring of end-expiratory lung volume change. Intensive Care Med. 2003;29:37–43.
Victorino JA, Borges JB, Okamoto VN, Matos GF, Tucci MR, Caramez MP, Tanaka H, Sipmann FS, Santos DC, Barbas CS, et al. Imbalances in regional lung ventilation: a validation study on electrical impedance tomography. Am J Respir Crit Care Med. 2004;169:791–800.
Frerichs I, Amato MB, van Kaam AH, Tingay DG, Zhao Z, Grychtol B, Bodenstein M, Gagnon H, Bohm SH, Teschner E, et al. Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group. Thorax. 2017;72:83–93.
Borges JB, Suarez-Sipmann F, Bohm SH, Tusman G, Melo A, Maripuu E, Sandstrom M, Park M, Costa EL, Hedenstierna G, Amato M. Regional lung perfusion estimated by electrical impedance tomography in a piglet model of lung collapse. J Appl Physiol (1985). 2012;112:225–36.
Lindgren S, Odenstedt H, Erlandsson K, Grivans C, Lundin S, Stenqvist O. Bronchoscopic suctioning may cause lung collapse: a lung model and clinical evaluation. Acta Anaesthesiol Scand. 2008;52:209–18.
Eichler L, Mueller J, Grensemann J, Frerichs I, Zollner C, Kluge S. Lung aeration and ventilation after percutaneous tracheotomy measured by electrical impedance tomography in non-hypoxemic critically ill patients: a prospective observational study. Ann Intensive Care. 2018;8:110.
Costa EL, Chaves CN, Gomes S, Beraldo MA, Volpe MS, Tucci MR, Schettino IA, Bohm SH, Carvalho CR, Tanaka H, et al. Real-time detection of pneumothorax using electrical impedance tomography. Crit Care Med. 2008;36:1230–8.
Morais CC, De Santis Santiago RR, Filho JR, Hirota AS, Pacce PH, Ferreira JC, Camargo ED, Amato MB, Costa EL. Monitoring of Pneumothorax Appearance with Electrical Impedance Tomography during recruitment maneuvers. Am J Respir Crit Care Med. 2017;195:1070–3.
Frerichs I, Hahn G, Golisch W, Kurpitz M, Burchardi H, Hellige G. Monitoring perioperative changes in distribution of pulmonary ventilation by functional electrical impedance tomography. Acta Anaesthesiol Scand. 1998;42:721–6.
Frerichs I. Electrical impedance tomography (EIT) in applications related to lung and ventilation: a review of experimental and clinical activities. Physiol Meas. 2000;21:R1–21.
Fieselmann A, Kowarschik M, Ganguly A, Hornegger J, Fahrig R. Deconvolution-based CT and MR Brain Perfusion Measurement: theoretical model revisited and practical implementation details. Int J Biomed Imaging. 2011;2011:467563.
Xin Y, Kim T, Winkler T, Brix G, Gaulton T, Gerard SE, Herrmann J, Martin KT, Victor M, Reutlinger K, et al. Improving pulmonary perfusion assessment by dynamic contrast-enhanced computed tomography in an experimental lung injury model. J Appl Physiol (1985). 2023;134:1496–507.
Yoshida T, Torsani V, Gomes S, De Santis RR, Beraldo MA, Costa EL, Tucci MR, Zin WA, Kavanagh BP, Amato MB. Spontaneous effort causes occult pendelluft during mechanical ventilation. Am J Respir Crit Care Med. 2013;188:1420–7.
Morais CCA, Koyama Y, Yoshida T, Plens GM, Gomes S, Lima CAS, Ramos OPS, Pereira SM, Kawaguchi N, Yamamoto H, et al. High positive end-expiratory pressure renders spontaneous effort Noninjurious. Am J Respir Crit Care Med. 2018;197:1285–96.
Macklem PT. Airway obstruction and collateral ventilation. Physiol Rev. 1971;51:368–436.
Kuriyama T, Wagner WW Jr. Collateral ventilation may protect against high-altitude pulmonary hypertension. J Appl Physiol Respir Environ Exerc Physiol. 1981;51:1251–6.
Ingenito EP, Reilly JJ, Mentzer SJ, Swanson SJ, Vin R, Keuhn H, Berger RL, Hoffman A. Bronchoscopic volume reduction: a safe and effective alternative to surgical therapy for emphysema. Am J Respir Crit Care Med. 2001;164:295–301.
Pereira SM, Tucci MR, Morais CCA, Simoes CM, Tonelotto BFF, Pompeo MS, Kay FU, Pelosi P, Vieira JE, Amato MBP. Individual Positive End-Expiratory Pressure Settings Optimize Intraoperative Mechanical Ventilation and reduce postoperative atelectasis. Anesthesiology. 2018;129:1070–81.
Joyce CJ, Baker AB, Kennedy RR. Gas uptake from an unventilated area of lung: computer model of absorption atelectasis. J Appl Physiol (1985). 1993;74:1107–16.
Dantzker DR, Wagner PD, West JB. Instability of lung units with low Va-Q ratios during O2 breathing. J Appl Physiol. 1975;38:886–95.
Dale WA, Rahn H. Rate of gas absorption during atelectasis. Am J Physiol. 1952;170:606–13.
Sylvester JT, Shimoda LA, Aaronson PI, Ward JP. Hypoxic pulmonary vasoconstriction. Physiol Rev. 2012;92:367–520.
Brusasco V, Martinez F. Chronic obstructive pulmonary disease. Compr Physiol. 2014;4:1–31.
Kuriyama T, Latham LP, Horwitz LD, Reeves JT, Wagner WW Jr. Role of collateral ventilation in ventilation-perfusion balance. J Appl Physiol Respir Environ Exerc Physiol. 1984;56:1500–6.
Pizarro C, Ahmadzadehfar H, Essler M, Tuleta I, Fimmers R, Nickenig G, Skowasch D. Effect of endobronchial valve therapy on pulmonary perfusion and ventilation distribution. PLoS ONE. 2015;10:e0118976.
Thomsen C, Theilig D, Herzog D, Poellinger A, Doellinger F, Schreiter N, Schreiter V, Schurmann D, Temmesfeld-Wollbrueck B, Hippenstiel S, et al. Lung perfusion and emphysema distribution affect the outcome of endobronchial valve therapy. Int J Chron Obstruct Pulmon Dis. 2016;11:1245–59.
Labarca G, Uribe JP, Pacheco C, Folch E, Kheir F, Majid A, Jantz MA, Mehta HJ, Patel N, Herth FJF, Fernandez-Bussy S. Bronchoscopic lung volume reduction with Endobronchial Zephyr Valves for severe Emphysema: a systematic review and Meta-analysis. Respiration. 2019;98:268–78.
van Dijk M, Sue R, Criner GJ, Gompelmann D, Herth FJF, Hogarth DK, Klooster K, Kocks JWH, de Oliveira HG, Shah PL, et al. Expert Statement: Pneumothorax Associated with one-way valve therapy for Emphysema: 2020 update. Respiration. 2021;100:969–78.
Hartman JE, Vanfleteren L, van Rikxoort EM, Klooster K, Slebos DJ. Endobronchial valves for severe emphysema. Eur Respir Rev 2019, 28.
Gompelmann D, Benjamin N, Bischoff E, Kontogianni K, Schuhmann M, Hoffmann H, Heussel CP, Herth FJF, Eberhardt R. Survival after Endoscopic Valve Therapy in patients with severe Emphysema. Respiration. 2019;97:145–52.
Egenod T, Guibert N, Ammar Y, Kessler R, Toublanc B, Favrolt N, Briault A, Dutau H, Wallyn F, Lachkar S, et al. Endobronchial valves: 1st multicenter retrospective study on the 2-step approach. Respir Med Res. 2023;83:100957.
Born T, Von Mallinckrodt C, Grandjean P-A, Tekeli N. Bronchoscopic lung volume reduction: do sequential endobronchial valve placements reduce pneumothorax rate? In Interventional pulmonology; 2019.
Bellinger CR, Khan I, Chatterjee AB, Haponik EF. Bronchoscopy safety in patients with chronic obstructive lung disease. J Bronchol Interv Pulmonol. 2017;24:98–103.
Lentz RJ, Low SW, Saettele T, Rickman OB, Aboudara M, Maldonado F. Association between Inspired Oxygen Fraction and Pneumothorax after Endobronchial Valve Placement for Emphysema. Ann Am Thorac Soc. 2023;20:926–9.
Costa EL, Lima RG, Amato MB. Electrical impedance tomography. Curr Opin Crit Care. 2009;15:18–24.
Fessler HE, Scharf SM, Permutt S. Improvement in spirometry following lung volume reduction surgery: application of a physiologic model. Am J Respir Crit Care Med. 2002;165:34–40.
Acknowledgements
Not applicable.
Funding
This work was supported by the FAPESP (2012-00100-2), and the Grant Agency of the Czech Republic (Grant No. GA ČR 22–34020 S). The funders played no role in the design and conduct of the study; interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication. The opinions, results, and conclusions reported in this paper are those of the authors.
Author information
Authors and Affiliations
Contributions
VT designed the study, conducted the study, analyzed the data, interpreted all data, wrote the manuscript, and revised the manuscript. PFGC designed the study, conducted the study, analyzed the data, interpreted all data, wrote the manuscript, revised the manuscript, and organized the study as a supervisor. JBB analyzed the data, interpreted all data, wrote the manuscript, and revised the manuscript. SG designed the study, conducted the study, and revised the manuscript. HTM, AFC, RRSS, CKN, MFF, and MAB conducted the study, analyzed the data, and revised the manuscript. MHVJ analyzed the data, interpreted all data, and revised the manuscript. MM interpreted all data, organized the study as a supervisor, and revised the manuscript. PMPF interpreted all data, organized the study as a supervisor, and revised the manuscript. MBPA designed the study, interpreted all data, revised the manuscript, and organized the study as a supervisor.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This study was approved by the ethics committee for experimental studies of the Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil (CEUA 200 − 12), and by the ethics committee for clinical studies (CAAe 43250215.0.1001.5327 and CAPPesq 0689 − 11).
Consent for publication
Not applicable.
Competing interests
MBPA reports that his research laboratory has received grants in the last five years from the Covidien/Medtronics (mechanical ventilation), Orange Med/Nihon Koden (mechanical ventilation) and Timpel S.A (electrical impedance tomography). MBPA is also a minority shareholder in Timpel S.A. JBB works as an external clinical consultant for Timpel S.A. (electrical impedance tomography). The other authors declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Torsani, V., Cardoso, P.F.G., Borges, J.B. et al. First real-time imaging of bronchoscopic lung volume reduction by electrical impedance tomography. Respir Res 25, 264 (2024). https://doi.org/10.1186/s12931-024-02877-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12931-024-02877-0